NCT01274494

Brief Summary

The aim of this multi-centre survey is to assess treatment adherence and quality of life in a Jordanian and Lebanese population newly diagnosed with hypertension or with uncontrolled essential hypertension being on antihypertensive treatment for at least 6 months.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,501

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2011

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 11, 2011

Completed
4 months until next milestone

Study Start

First participant enrolled

May 1, 2011

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
Last Updated

September 11, 2013

Status Verified

September 1, 2013

Enrollment Period

1.3 years

First QC Date

January 10, 2011

Last Update Submit

September 10, 2013

Conditions

Keywords

Hypertension

Outcome Measures

Primary Outcomes (1)

  • Compliance rate

    Identify the percentage of subjects compliant to their antihypertensive treatment.

    6 months

Secondary Outcomes (5)

  • Health Related Quality of Life (MINICHAL Score)

    6 months

  • Type of pharmacological treatments

    6 months

  • Factors affecting adherence to treatment

    6 months

  • Compliance rate by antihypertensive regimen used

    6 months

  • Percentage of controlled patients

    6 months

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

multi-centre survey of patients

You may qualify if:

  • Patients older than 21 years of age
  • Patients newly diagnosis with essential hypertension or with hypertension that is uncontrolled after being under the same antihypertensive treatment for at least 6 months (based on the criteria established by the Joint National Committee VII)
  • Patients capable of providing an informed consent

You may not qualify if:

  • Patients with secondary hypertension
  • Pregnant women or nursing mothers
  • Patients with acute illnesses or psychiatric diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2011

First Posted

January 11, 2011

Study Start

May 1, 2011

Primary Completion

September 1, 2012

Study Completion

September 1, 2012

Last Updated

September 11, 2013

Record last verified: 2013-09